Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Increasing the number of options.

<< Previous

Bullboard Posts

Next >>

Comment by TMAZZ21on Apr 10, 2023 10:24am

78 Views

Post# 35386566

RE:RE:Increasing the number of options.

Lesalpes29 wrote: Please people vote a VERY BIG NO.

Will do, I have a substantial number of shares, only issue is that I stopped all paper mail coming to my home address, can one won virtually?
If so how?

Thanks

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market